AGM/EGMJul 24, 2026, 04:27 PM
OS Therapies Sets 2026 AGM, Proposes 5M Share Increase to Incentive Plan
AI Summary
OS Therapies Inc. announced its 2026 Annual Meeting of Stockholders to be held virtually on September 9, 2026. Stockholders will vote on the election of six directors, the ratification of MaloneBailey, LLP as the independent auditor for 2026, and a significant amendment to the 2023 Incentive Compensation Plan. The proposed amendment seeks to increase the number of shares available for issuance under the plan by 5,000,000, bringing the total to 15,000,000 shares, and eliminate per-person award limitations. The record date for stockholders entitled to vote is July 21, 2026.
Key Highlights
- Annual Meeting of Stockholders scheduled for September 9, 2026, virtually.
- Proposes election of six directors to serve until the 2027 annual meeting.
- Seeks approval for 5,000,000 share increase to 2023 Incentive Compensation Plan.
- Total shares available for incentive plan would be 15,000,000.
- Proposes ratification of MaloneBailey, LLP as independent auditor for 2026.
- Record date for voting is July 21, 2026.
- Common stock outstanding: 45,538,101 shares; Series A preferred: 392,500 shares.
- Fair market value of common stock on record date was $1.56.
Price Impact
More from OSTX